Taken with a carbohydrate meal, apple cider vinegar reliably flattens the rise in blood sugar and insulin; taken daily for two to three months it lowers fasting blood sugar in type 2 diabetes. Weight, waist, and total cholesterol shift slightly. Daily acid contact wears tooth enamel, which does not grow back. Nothing in the record supports the larger marketplace claims. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting glucose | 75–85 mg/dL | Primary efficacy endpoint |
| HbA1c | 4.8–5.3% | Confirms the fasting change is sustained |
| Fasting insulin | 2–5 µIU/mL | Separates improving insulin resistance from glucose bought with more insulin |
| Serum potassium | 4.2–4.7 mmol/L | Chronic acid load; basis of the digoxin interaction |
| ALT | 10–20 U/L | Screens for idiosyncratic liver injury |
| Triglycerides | Below 80 mg/dL | Secondary lipid endpoint; subgroup benefit only |
| Total cholesterol | 160–200 mg/dL | The lipid fraction that actually moved |
| Basic erosive wear examination score | 0–2 (no or initial enamel loss) | The dominant long-term harm; silent |
| Post-meal glucose excursion (continuous glucose monitor) | Peak rise below 30 mg/dL above pre-meal | Immediate readout of individual response |
| Bone mineral density T-score | Above −1.0 | Multi-year high-dose users only |
Cadence: Fasting glucose and potassium at 8 weeks; metabolic and liver panel at 12 weeks; then blood work every 6 months and dental erosion assessment annually while daily use continues. On insulin, a sulfonylurea, digoxin, or a diuretic, potassium and glucose move to 4 weeks.